Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 264 | - | - | 65 | 24.6 | 52 | 19.7 | 117 | 44.3 | 30 | 11.4 |
2015-2019 | 280 | - | - | 61 | 21.8 | 64 | 22.9 | 120 | 42.9 | 35 | 12.5 |
2014-2018 | 271 | - | - | 56 | 20.7 | 61 | 22.5 | 119 | 43.9 | 35 | 12.9 |
2013-2017 | 256 | - | - | 46 | 18.0 | 59 | 23.0 | 112 | 43.8 | 39 | 15.2 |
2012-2016 | 261 | - | - | 45 | 17.2 | 56 | 21.5 | 120 | 46.0 | 40 | 15.3 |
2011-2015 | 276 | - | - | 42 | 15.2 | 58 | 21.0 | 132 | 47.8 | 44 | 15.9 |
2010-2014 | 264 | - | - | 38 | 14.4 | 52 | 19.7 | 130 | 49.2 | 44 | 16.7 |
2009-2013 | 254 | - | - | 34 | 13.4 | 50 | 19.7 | 130 | 51.2 | 40 | 15.7 |
2008-2012 | 267 | - | - | 35 | 13.1 | 57 | 21.3 | 129 | 48.3 | 46 | 17.2 |
2007-2011 | 270 | - | - | 35 | 13.0 | 58 | 21.5 | 123 | 45.6 | 54 | 20.0 |
2006-2010 | 251 | - | - | 31 | 12.4 | 53 | 21.1 | 116 | 46.2 | 51 | 20.3 |
2005-2009 | 255 | - | - | 29 | 11.4 | 54 | 21.2 | 114 | 44.7 | 58 | 22.7 |
2004-2008 | 264 | - | - | 36 | 13.6 | 55 | 20.8 | 105 | 39.8 | 68 | 25.8 |
2003-2007 | 257 | - | - | 36 | 14.0 | 44 | 17.1 | 109 | 42.4 | 68 | 26.5 |
2002-2006 | 271 | - | - | 42 | 15.5 | 52 | 19.2 | 113 | 41.7 | 64 | 23.6 |
2001-2005 | 269 | - | - | 40 | 14.9 | 52 | 19.3 | 112 | 41.6 | 65 | 24.2 |
2000-2004 | 269 | - | - | 47 | 17.5 | 51 | 19.0 | 111 | 41.3 | 60 | 22.3 |
1999-2003 | 263 | - | - | 46 | 17.5 | 51 | 19.4 | 118 | 44.9 | 48 | 18.3 |
1998-2002 | 278 | - | - | 46 | 16.5 | 61 | 21.9 | 123 | 44.2 | 48 | 17.3 |
1997-2001 | 266 | - | - | 45 | 16.9 | 55 | 20.7 | 121 | 45.5 | 45 | 16.9 |
1996-2000 | 265 | - | - | 47 | 17.7 | 56 | 21.1 | 120 | 45.3 | 42 | 15.8 |
1995-1999 | 265 | - | - | 55 | 20.8 | 51 | 19.2 | 111 | 41.9 | 48 | 18.1 |
1994-1998 | 258 | - | - | 54 | 20.9 | 50 | 19.4 | 101 | 39.1 | 53 | 20.5 |
1993-1997 | 242 | - | - | 54 | 22.3 | 42 | 17.4 | 93 | 38.4 | 53 | 21.9 |
1992-1996 | 228 | - | - | 46 | 20.2 | 42 | 18.4 | 85 | 37.3 | 55 | 24.1 |
1991-1995 | 226 | - | - | 50 | 22.1 | 36 | 15.9 | 83 | 36.7 | 57 | 25.2 |
1990-1994 | 216 | - | - | 38 | 17.6 | 37 | 17.1 | 90 | 41.7 | 51 | 23.6 |
1989-1993 | 215 | - | - | 36 | 16.7 | 38 | 17.7 | 89 | 41.4 | 52 | 24.2 |
1988-1992 | 199 | - | - | 34 | 17.1 | 35 | 17.6 | 85 | 42.7 | 45 | 22.6 |
1987-1991 | 188 | - | - | 35 | 18.6 | 32 | 17.0 | 82 | 43.6 | 39 | 20.7 |
1986-1990 | 173 | - | - | 31 | 17.9 | 37 | 21.4 | 71 | 41.0 | 34 | 19.7 |
1985-1989 | 164 | 1 | 0.6 | 30 | 18.3 | 40 | 24.4 | 67 | 40.9 | 26 | 15.9 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |